ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. - Wikidata - wikimedia - TriplyDB

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

http://www.wikidata.org/entity/Q38162673

about

Role of imaging in the evaluation of inflammatory bowel disease: How much is too much?Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future Minimally invasive surgery for paediatric inflammatory bowel disease: Personal experience and literature review Management of ulcerative colitis Management of Crohn's disease The diagnostic approach to monogenic very early onset inflammatory bowel disease Intestinal Behçet and Crohn's disease: two sides of the same coin.Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases.16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry.A snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study.Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study Characteristics of Pediatric Crohn's Disease in Saudi Children: A Multicenter National Study.Nutritional status of children with inflammatory bowel disease in Saudi Arabia.Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn's disease Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study.Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort.Disease impact on the quality of life of children with inflammatory bowel disease.Pediatric ulcerative colitis: a practical guide to management.Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.Ultrasonographic imaging of inflammatory bowel disease in pediatric patients.Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors.Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.Classification of Paediatric Inflammatory Bowel Disease using Machine Learning Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.Inflammatory Bowel Disease in Childhood and Adolescence.An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets.Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents.Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years.Eosinophilic colitis in children.Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn's Disease: Practice in China.Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.

P2860

Q26765150-737F808B-F90E-48AD-A4C8-8EFDC3803371 Q26765893-9956985A-9492-4971-B177-3CDB596BE8D1 Q26777423-854D773A-CB13-49A6-BFCD-1E6755F0B7F7 Q26778250-B3E86270-52E7-41BB-8F03-40E53A59C511 Q26778252-E4F1E8B9-3C84-47EE-8AB1-43ED954B744E Q27015077-EBFBD4E3-CB58-404C-998C-CA4A86F954BA Q33582640-0B509C97-193E-4416-95A1-04A3AB57504E Q33774260-22AA98C8-DDF4-4524-8BC0-0F51F6CFAFFF Q33879834-9C9A21E6-6362-4293-8255-C24DCE589BED Q35088619-71CF8CF5-C5C4-4280-B485-B5665E9C4E43 Q35128945-F8A6B19D-92DE-412F-95DF-565901EBD627 Q35182768-B6631B0D-6A9F-4903-91AF-3F434D511F09 Q35862736-E053FC0D-140E-43A2-AFE9-A00D5193EE20 Q36088921-D44A7BC0-37B5-4500-9BF7-D876454F98C8 Q36265752-61563CB2-2EDA-4D0C-A1A0-3BA5EEE8111D Q36453521-A8C4DC7D-3547-4502-9262-9F607D2C75B4 Q36495342-16FF6779-E9D9-4DBB-9817-8ECCB07AB986 Q36792505-76AD9237-E581-416A-A2C0-5CA784CFFDBC Q37030211-88DC91A1-A6E4-4A9E-843A-DFC5654A29F8 Q37118437-B8A5C1C4-4119-47B5-8657-90E4FB16E31B Q37124803-573441BD-D396-4DE6-A5C9-E76501270580 Q37210128-1D86915F-F71F-4162-A6D4-7D2523DDCA5E Q37273489-3DFA4D83-2830-4609-A54E-0A6F0F821311 Q37538958-8ACCBA07-42CF-4ED3-877D-73B9202E1F02 Q37643994-EACAD5C2-1C47-40D7-B474-E4646CEF30C0 Q38203832-77DF936E-7CAB-4386-9A16-E3DC079F5F56 Q38376238-8445A1BE-10CD-4B13-B59D-4A80B60EADF6 Q38466643-C22A19DF-C66B-41E8-8EF1-C001B6A81C3E Q38619764-28C79BE9-00EC-449D-BB35-88480E6243B9 Q38625783-C397F501-81CD-41C1-AFC4-253DDD6E269F Q38762754-B4E98092-551A-4CFC-9F48-E8DE1CB57BE0 Q38993044-E0D9FF9C-BC6D-444B-8746-DE1CE45F54AC Q39361742-92938737-B7CF-4154-947E-A7B25AEC3ED8 Q39389508-663EA3B5-1716-44C4-A127-C15C959C8CD3 Q39556267-CE6A7B0C-1DD4-4483-BEEE-E012B76F6823 Q39682665-4F3FB311-43EB-4FEE-8493-D54D16910AD2 Q40307888-1C8B48B5-7AB2-436E-B6B9-28D4E16963F5 Q40739614-B5074394-92F1-4EE9-85DA-B6F5B6E69E7C Q40803302-C4A0637E-DEEC-4F04-87E6-DD5572387CC6 Q41111300-55DA64BA-D6D8-4088-93C1-F64E003AB0FC

P2860

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

http://www.wikidata.org/entity/Q38162673

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

ESPGHAN revised porto criteria ...... e in children and adolescents.

@en

type

label

ESPGHAN revised porto criteria ...... e in children and adolescents.

@en

prefLabel

ESPGHAN revised porto criteria ...... e in children and adolescents.

@en

P1433

Q38162673-8AD81B66-BD69-4A63-8543-D885D6620AD9

P1476

Q38162673-58794B6E-860D-4D90-A410-0694A4E8C8C8

P2093

Q38162673-0509941A-E633-4B21-A79C-A925E36AF4FA

Q38162673-0509D040-AD2F-456D-8B5E-9EFD93FEC95B

Q38162673-194BD44E-3366-4FB0-91EE-C13FCA2F80B7

Q38162673-1F8E277D-DB72-48FF-88FF-10B4D231A909

Q38162673-402838CE-CB4B-456B-B8BB-863356412199

Q38162673-588BF71B-8D51-42A8-BA35-D5FBB6174A7B

Q38162673-5CD67536-5FED-46CF-A062-BF0A739BF57F

Q38162673-76B30B03-2842-4A21-8348-B8C1CDF41749

Q38162673-79C62A10-22E1-4CFB-9D2E-4EA8254D5509

Q38162673-7DF9C4C0-284D-4D08-AA5C-C37EC91EE815

P304

Q38162673-D6D74F49-EAB3-4587-B34E-8FA7029F235B

P31

Q38162673-DC20D8BF-154D-42A0-8984-9AABE08025F3

P356

Q38162673-8B4BE246-6BFA-4D92-8C1C-E7588D9B3B3A

P407

Q38162673-AE846B1F-50D6-4790-B2CA-FB2A3FB4B202

P433

Q38162673-0408ABE8-E2AD-402A-B263-6F6B6F9538FC

P478

Q38162673-02CD7BC3-EB9D-4202-9FF0-43A9532799C9

P50

Q38162673-5A9155B5-5F20-4B1D-9347-2152ED832AE9

Q38162673-859A2F1E-93B0-47C3-B80A-FDC647B4EFBC

Q38162673-D970AC57-1FC2-47D0-B479-4707343787EF

Q38162673-FE732B3F-6C2B-40A7-8A7A-D7D88E830C7D

P577

Q38162673-BEDE831F-9E43-452C-846E-9BCFA091182E

P698

Q38162673-F7E0DAFA-5A60-4810-80B5-E5C183BC4A67

P921

Q38162673-4D79D236-F572-4DF3-8054-B369898E4789

Q38162673-AE5D9680-B657-4FD0-8C0B-454BBA220771

P356

MPG.0000000000000239

P1433

Journal of Pediatric Gastroenterology and Nutrition

P1476

ESPGHAN revised porto criteria ...... e in children and adolescents.

@en

P2093

Anders Paerregaard

http://www.w3.org/2001/XMLSchema#string

Arie Levine

http://www.w3.org/2001/XMLSchema#string

Dan Turner

http://www.w3.org/2001/XMLSchema#string

David C Wilson

http://www.w3.org/2001/XMLSchema#string

European Society of Pediatric Gastroenterology, Hepatology, and Nutrition

http://www.w3.org/2001/XMLSchema#string

Frank M Ruemmele

http://www.w3.org/2001/XMLSchema#string

Gabor Veres

http://www.w3.org/2001/XMLSchema#string

Gigi Veereman-Wauters

http://www.w3.org/2001/XMLSchema#string

Javier Martin de Carpi

http://www.w3.org/2001/XMLSchema#string

Johanna C Escher

http://www.w3.org/2001/XMLSchema#string

P304

795-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPG.0000000000000239

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Cucchiara

Annamaria Staiano

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24231644

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases